Free Trial

Sage Therapeutics (SAGE) SEC Filings & 10K Form

Sage Therapeutics logo
$5.27 -0.08 (-1.50%)
(As of 12/17/2024 ET)

Recent Sage Therapeutics SEC Filings

DateFilerForm TypeView
12/13/2024
7:47 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:42 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
5:40 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:14 PM
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:56 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
11/04/2024
2:28 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:10 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
3:23 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/01/2024
3:24 PM
Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:10 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:20 PM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
10:37 AM
Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/17/2024
6:11 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
5:37 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
6:07 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
5:33 AM
Sage Therapeutics (Filer)
Form S-3ASR
07/31/2024
3:10 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
3:15 PM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
5:39 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
3:57 PM
Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:57 PM
Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:57 PM
COLA MICHAEL F (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:58 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:58 PM
Germano Geno J (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:58 PM
Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:58 PM
JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
11:15 AM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
06/10/2024
8:48 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
06/06/2024
8:54 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
04/25/2024
6:15 AM
Sage Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
5:46 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:07 PM
Sage Therapeutics (Filer)
Form DEF 14A
04/24/2024
3:10 PM
Sage Therapeutics (Filer)
Form DEFA14A
04/24/2024
3:13 PM
Sage Therapeutics (Filer)
Form ARS
04/19/2024
7:31 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
5:35 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
7:34 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:49 AM
Sage Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
Musk threatens Liberal’s fake “energy crisis” (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now
02/14/2024
6:20 AM
Sage Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
6:09 AM
RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
Form SC 13G
02/14/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
4:13 PM
Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/13/2024
5:28 AM
Sage Therapeutics (Subject)
Form SC 13G/A
02/13/2024
5:28 AM
BB BIOTECH AG (Filed by)
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Sage Therapeutics (Subject)
Form SC 13G/A
02/08/2024
9:17 AM
Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/31/2024
4:25 PM
Sage Therapeutics (Subject)
Form SC TO-I/A
01/31/2024
3:50 PM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
9:04 AM
Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/23/2024
7:13 AM
Sage Therapeutics (Subject)
Form SC TO-I
01/08/2024
5:45 AM
Sage Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:07 PM
IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:07 PM
Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
7:30 AM
Sage Therapeutics (Filer)
Form DEF 14A
12/19/2023
7:32 AM
Sage Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SAGE) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners